Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
---|
09/25/2003 | US20030181728 Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function |
09/25/2003 | US20030181726 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists |
09/25/2003 | US20030181508 For therapy of attention-deficit disorder, depression, obesity, Parkinson's disease, a tic disorder, or an addictive disorder |
09/25/2003 | US20030181499 For use as anti-human immunodeficiency virus (HIV) drugs |
09/25/2003 | US20030181489 For therapy and prophylaxis of cough in warm-blooded animals |
09/25/2003 | US20030181454 Nitrogen compounds and prodrugs used as type-II secretory phospholipase(sPLA2) agonists or antagonists, for prevention cancer, cirrhosis, Alzheimer's disease and/or arteriosclerosis |
09/25/2003 | US20030181446 Novel N-acylated heterocycles |
09/25/2003 | US20030181442 Carbamides such as N-(3-tert-butylphenyl)-N'-(4-(3-(N-methyl-carbamoyl)phenoxy)phenyl urea, used as enzyme inhibitors and as anticarcinogenic agents |
09/25/2003 | US20030181437 By reaction of pyrrolobenzothiazepin-9-one with amine to give the corresponding enamine, which is subsequently transformed into the final compound |
09/25/2003 | US20030180635 Visible radiation sensitive composition |
09/25/2003 | CA2479352A1 Carboxylic acid compound and a pharmaceutical agent comprising the compound as an active ingredient |
09/25/2003 | CA2478731A1 Carbamates as hiv protease inhibitors |
09/25/2003 | CA2478211A1 Nk1 antagonists |
09/25/2003 | CA2478172A1 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators |
09/24/2003 | EP1346983A2 Phthalimido arylpiperazines as alpha 1A receptor antagonists useful in the treatment of benign prostatic hyperplasia |
09/24/2003 | EP1346982A1 Vla-4 inhibitors |
09/24/2003 | EP1345921A1 3-indoline derivatives useful in the treatment of psychiatric and neurologic disorders |
09/24/2003 | EP1345908A2 Process for the preparation of alpha-aminosubstituted carboxylic acid amides |
09/24/2003 | EP1345901A2 Process for making amlodipine, derivatives thereof, and precursors therefor |
09/24/2003 | EP1345898A2 Teracyclic carbazole derivates and their use as spla2 inhibitors |
09/24/2003 | EP1345897A1 Chemical process and new intermediates |
09/24/2003 | EP1345891A1 Glucagon antagonist/inverse agonist |
09/24/2003 | EP1345890A1 Glucagon antagonists/inverse agonists |
09/24/2003 | EP1150953B1 Indole derivatives and their use as mcp-1 receptor antagonists |
09/24/2003 | CN1444573A Carboxamide compounds and their use as antagonists of human 11CBY receptor |
09/24/2003 | CN1122001C Method of separating optical isomers |
09/23/2003 | US6624309 Administering 4-heterocyclicbenzamide derivative |
09/23/2003 | US6624152 Inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. This invention relates to pharmaceutical formulations comprising these compounds and methods of using them for inflammatory and autoimmune diseases |
09/23/2003 | CA2295992C Method for preparing a substituted perhydroisoindole |
09/23/2003 | CA2218555C Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs |
09/18/2003 | WO2003076405A1 Monocyclic aroylpyridinones as antiinflammatory agents |
09/18/2003 | WO2003076374A1 PROCESS FOR PRODUCING trans-4-AMINO-1-CYCLOHEXANECARBOXYLIC ACID DERIVATIVE |
09/18/2003 | WO2003075907A2 Small molecule entry inhibitors |
09/18/2003 | WO2003075857A2 Amino-methyl substituted tetracycline compounds |
09/18/2003 | WO2003075836A2 Cathepsin cysteine protease inhibitors |
09/18/2003 | WO2003053368A3 Chalcone derivatives and their use to treat diseases |
09/18/2003 | WO2003051838A3 Protein kinase inhibitors |
09/18/2003 | WO2003048122A3 Inhibitors of cytosolic phospholipase a2 |
09/18/2003 | WO2003045392A3 Use of n-(indolcarbonyl-)piperazine derivatives |
09/18/2003 | WO2002038557A9 Benzoylbenzofurane derivatives for treatment of cardiac arrhythmia |
09/18/2003 | US20030176701 Di-or triaza-spiro [4,5] decane derivatives |
09/18/2003 | US20030176506 For therapy of leukemia or other forms of cancer or for treating disease conditions caused by apoptosis of cells |
09/18/2003 | US20030176497 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments |
09/18/2003 | US20030176496 Administering an antiproliferative agent in combination with a potentiating effective amount of a N- substituted dithiocarbamate ester or a pharmaceutically acceptable salt thereof |
09/18/2003 | US20030176487 For therapy and prophylaxis of disorders related to unregulated tyrosine kinase signal transduction, including cell proliferative and metabolic disorders |
09/18/2003 | US20030176486 For use as an inhibitor of lipopolysaccharides (LPS) |
09/18/2003 | US20030176485 Calcium receptor active compounds |
09/18/2003 | US20030176463 For therapy of disease states resulting from angiogenesis; can be administered orally |
09/18/2003 | US20030176433 For therapy and prophylaxis of hepatitis C virus (HCV) infection |
09/18/2003 | US20030176432 Cyclic and heterocyclic N-substituted alpha-iminohydroxamic and -carboxylic acids |
09/18/2003 | US20030176400 For therapy of allergic diseases such as allergic rhinitis, allergic conjunctivitis, atopic dermatitis, bronchial rhinitis, allergic conjunctivitis, atopic dermatitis, bronchial asthma, food allergy, etc., systemic mastocytosis |
09/18/2003 | US20030173552 Cathodic compound includes a bi-pyrimidinium compound |
09/18/2003 | CA2478936A1 Monocyclic aroylpyridinones as antiinflammatory agents |
09/17/2003 | EP1344773A1 Growth hormone secretagogues |
09/17/2003 | EP1343796A2 Compounds and methods |
09/17/2003 | EP1343789A1 Tricyclic derivatives of indole with antiangiogenic activity |
09/17/2003 | EP1343768A1 Aryl and aminoaryl substituted serotonin receptor agonist and antagonist ligands |
09/17/2003 | EP1343759A1 Benzo(f) isoindol derivatives and their use as ep4 receptor ligands |
09/17/2003 | EP1343758A1 Substituted bis-indole derivatives useful as contrast agents, pharmaceutical compositions containing them and intermediates for producing them |
09/17/2003 | EP1343757A1 Indole derivatives |
09/17/2003 | EP1343756A2 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands |
09/17/2003 | EP1343753A2 Antimicrobial agents |
09/17/2003 | EP1343751A2 Cyclic derivatives as modulators of chemokine receptor activity |
09/17/2003 | EP1343561A1 Serine protease inhibitors |
09/17/2003 | EP1343499A2 Heterocyclic substituted 2-methyl-benzimidazole antiviral agents |
09/17/2003 | EP1079828B1 Compositions comprising 5-hydroxyindole as a modulator of a nicotinic receptor |
09/17/2003 | EP1058548B1 The use of isatin and oxindole derivatives in the preparation of a medicament for use in the treatment of mycobacterial disease |
09/17/2003 | EP0984777B1 Arylsubstituted piperazines useful in the treatement of benign prostatic hyperlasia |
09/17/2003 | EP0891329B1 Peptidyl compounds having mmp and tnf inhibitory activity |
09/17/2003 | CN1443188A Process for preparation of 9-amino substituted 9,10-dihydropyrrolo [2,1-b] [1,3] benzotiazepines |
09/17/2003 | CN1443179A Aniline derivatives |
09/17/2003 | CN1443165A Cyclopentanoindoles, compositions containing such compounds and methods of treatment |
09/17/2003 | CN1443162A New combination of serotonin agonist (5HT2) and antagonist (5HT6) as pharmaceutical formulation |
09/17/2003 | CN1443158A Sulfonic acid derivatives of hydroxamic acids and their use as medicinal products |
09/17/2003 | CN1121376C Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives and matrix metalloprotease inhibitors |
09/16/2003 | US6620832 Substituted ureas |
09/16/2003 | US6620813 Hydroxamate derivatives of non-steroidal anti-inflammatory drugs |
09/16/2003 | US6620806 Estrogen agonist/antagonist to prevente myocardial infarction or stroke, maintaining or improving vascular reactivity, treat renal failure, peripheral arterial occlusive disease, coronary artery disease, or raynaud's phenomenon |
09/16/2003 | CA2046429C Imide derivatives, and their production and use |
09/12/2003 | WO2003074628A1 Phosphorescent compositions and organic light emitting devices containing them |
09/12/2003 | WO2003074517A1 Indole-amid derivatives which possess glycogen phosphorylase inhibitory activity |
09/12/2003 | WO2003074486A1 Azaspiro compounds for the treatment of pain |
09/12/2003 | WO2003074485A2 Indole-amide derivatives and their use as glycogen phosphorylase inhibitors |
09/12/2003 | WO2003074484A1 Indolamid derivatives which possess glycogenphosphorylase inhibitory activity |
09/12/2003 | WO2003074467A2 Urea derivatives as hiv aspartyl protease inhibitors |
09/12/2003 | WO2003074091A2 Near infrared fluorescent contrast agent and method for fluorescence imaging |
09/12/2003 | WO2003074048A1 Method of treating osteoarthritis |
09/12/2003 | WO2003074047A1 Indole derivatives as modulators of potassium channels |
09/12/2003 | WO2003048081A3 Glycinamides as factor xa inhibitors |
09/12/2003 | WO2003016259A3 Compounds containing lactic acid elements, method for the production and use thereof as pharmaceutically active substances |
09/12/2003 | WO2002040486A3 METHODS OF TREATING p38 KINASE-ASSOCIATED CONDITIONS AND PYRROLOTRIAZINE COMPOUNDS USEFUL AS KINASE INHIBITORS |
09/12/2003 | WO2002022550A3 Chiral amino alcohols and process for preparation of same |
09/12/2003 | WO2002002488A9 Methods and compounds for modulating nuclear receptor coactivator binding |
09/12/2003 | CA2478272A1 Near infrared fluorescent contrast agent and method for fluorescence imaging |
09/12/2003 | CA2477717A1 Indolamid derivatives which possess glycogen phosphorylase inhibitory activity |
09/12/2003 | CA2477391A1 Method of treating osteoarthritis |
09/12/2003 | CA2477124A1 Azaspiro compounds for the treatment of pain |
09/11/2003 | US20030171593 Process for arylating or vinylating or alkynating a nucleophilic compound |
09/11/2003 | US20030171591 Process for producing optically active sulfoxide derivative |
09/11/2003 | US20030171585 Anti-inflammatory compounds |